Novartis U.S. Shares Fall After Multiple Sclerosis Trial Results
Novartis reported two late-stage studies of its multiple sclerosis pill showed a reduction in flare-ups below that achieved by a rival Roche drug.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.